Verizon gives customers more peace of mind with enhanced Home Device Protection service
April 25, 2024 09:00 ET
|
Verizon Sourcing LLC
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Research has shown that the average U.S. household has over $11,000 worth of home technology products1. As the number of devices we rely on at home...
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
April 25, 2024 08:45 ET
|
AIM ImmunoTech Inc.
OCALA, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s...
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
April 25, 2024 08:30 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 fourth quarter and year-end earnings release on...
ArcelorMittal S.A.: ArcelorMittal announces the publication of its first quarter 2024 sell-side analyst consensus figures
April 25, 2024 08:27 ET
|
ArcelorMittal S.A.
25 April 2024, 14:30 CET ArcelorMittal (‘the Company’) today announces the publication of its first quarter 2024 sell-side analyst consensus figures. The consensus figures are based on...
Theriva™ Biologics hablará sobre el diseño del ensayo VIRAGE, un estudio clínico de fase 2b de VCN-01 administrado sistémicamente en combinación con quimioterapia para el adenocarcinoma pancreático ductal, en la Reunión Anual de la Sociedad Americana de Oncología Clínica (ASCO) de 2024
April 25, 2024 08:15 ET
|
Theriva Biologics, Inc.
ROCKVILLE, Maryland, April 25, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), una empresa diversificada de fase clínica que desarrolla terapias diseñadas para tratar el cáncer y...
Theriva™ Biologics to Discuss the Trial Design for VIRAGE - a Phase 2b Clinical Study of Systemically Administered VCN-01 in Combination with Chemotherapy in Pancreatic Ductal Adenocarcinoma - at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 25, 2024 08:15 ET
|
Theriva Biologics, Inc.
ROCKVILLE, Md., April 25, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related...
Enviri Corporation to Participate in Upcoming Investor Conferences
April 25, 2024 08:00 ET
|
Enviri
PHILADELPHIA, April 25, 2024 (GLOBE NEWSWIRE) -- Enviri Corporation (NYSE: NVRI), a global, market-leading provider of environmental solutions for industrial and specialty waste streams, today...
Integer Holdings Corporation Reports First Quarter 2024 Results
April 25, 2024 08:00 ET
|
Integer Holdings Corporation
~ Strong start to the year with 1Q24 financial results ~~ Reiterate 2024 financial outlook ~ PLANO, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today...
FTI Consulting Reports Record First Quarter 2024 Financial Results
April 25, 2024 07:30 ET
|
FTI Consulting, Inc.
First Quarter 2024 Revenues of $928.6 Million, Up 15% Compared to $806.7 Million in Prior Year QuarterFirst Quarter 2024 EPS of $2.23, Up 66% Compared to $1.34 in Prior Year Quarter WASHINGTON,...
Amwell to Participate in Upcoming Investor Conference
April 25, 2024 07:00 ET
|
Amwell
Boston, April 25, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, announced that the company will participate in the Needham Technology, Media and Consumer...